Bon Natural Life Secures $22 Million Distribution Deal for Innovative Weight Loss Products in China and Southeast Asia

Reuters
Jul 21
<a href="https://laohu8.com/S/BON">Bon Natural Life</a> Secures $22 Million Distribution Deal for Innovative Weight Loss Products in China and Southeast Asia

Bon Natural Life Ltd. (Nasdaq: BON) has announced a $22 million non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. Under the 36-month contract, Huahai Keyuan will distribute Bon's innovative natural weight loss products across China and Southeast Asia. The products feature a "prebiotics + postbiotics" compound formula designed to deliver effective weight loss results without the need for restrictive dieting. This collaboration aligns with BON's strategy to tap into the burgeoning health and wellness market, leveraging Huahai Keyuan's expertise in marketing and brand expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020366), on July 21, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10